CI
SGYP

Cowen Inc’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Cowen Inc’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-350,000
Closed -$2.9M – 482
2015
Q2 		$2.9M Buy
+350,000
New +$1.7M 0.17% 98

Other funds holding SGYP

TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cowen Inc's SGYP Position: Q3 2016 in Review

Cowen Inc sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2016, closing a stake of 177,700 shares — an estimated $675K sold.

Cowen Inc first reported a position in SGYP in Q3 2014 and held it in 8 quarters. The position peaked at $1.7M in Q2 2015. 149 funds tracked by Wall St. Rank hold SGYP as of Q3 2016.

  • Cowen Inc reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2016 after selling out during the quarter.
  • Cowen Inc sold 177,700 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2016, an estimated $675K.
  • Cowen Inc first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2014 and held it in 8 quarters.
  • Cowen Inc's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.7M in Q2 2015.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2016.

Based on Cowen Inc's 13F filing for Q3 2016, filed 14 Nov 2016.